Community/Retail

National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to enactment of Oklahoma's S.B. 1150, legislation to boost transparency in generic prescription drug pricing and reimbursement.

Health care stakeholders across the nation are working to address public health needs in creative ways, and many of their solutions involve eliminating the prescription as a barrier to accessing health care.

The FDA has approved the first drug to treat delusions and hallucinations seen in some patients with Parkinson's disease.

Patients looking for a quick hangover cure may be disappointed to learn that many OTC products have little evidence to support their efficacy in treating hangover symptoms.